Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Pazopanib Hydrochloride in Treating Patients With Metastatic Melanoma That Cannot be Removed by Surgery

NCT00861913

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
View Trial Details
Completed

Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma

NCT00329719

Conditions
Adult Glioblastoma, Adult Gliosarcoma, Astrocytoma, +18 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Smilow Cancer Hospital Care Center at Saint Francis Hartford, Connecticut, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 190 locations
View Trial Details
Completed

LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab

NCT01986426

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +23 more
Locations
  • Jules Bordet Institute Brussels, Belgium
  • Cliniques Universitaires St-Luc, Service d'oncologie médicale Brussels, Belgium
  • Institut Curie Paris, France
  • Institute Gustave Roussy Paris, France
View all 14 locations
View Trial Details
Completed

A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma

NCT02272855

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • Clinical Site San Francisco, California, United States
  • Clinical Site Atlanta, Georgia, United States
  • Clinical Site Portland, Oregon, United States
  • Clinical Site Bethlehem, Pennsylvania, United States
View Trial Details
Completed

Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors

NCT01560260

Conditions
Abnormalities, Multiple, Cardiovascular Diseases, Carney Complex, +25 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Dana-Farber/Harvard Cancer Center Boston, Massachusetts, United States
View Trial Details

Related conditions